Madrigal Pharmaceuticals Stock Technical Analysis
MDGL Stock | USD 327.03 10.24 3.04% |
As of the 28th of March, Madrigal Pharmaceuticals secures the Mean Deviation of 2.97, risk adjusted performance of 0.0672, and Downside Deviation of 4.15. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Madrigal Pharmaceuticals, as well as the relationship between them. Please verify Madrigal Pharmaceuticals treynor ratio, and the relationship between the standard deviation and downside variance to decide if Madrigal Pharmaceuticals is priced some-what accurately, providing market reflects its recent price of 327.03 per share. Given that Madrigal Pharmaceuticals has jensen alpha of 0.318, we recommend you to check Madrigal Pharmaceuticals's last-minute market performance to make sure the company can sustain itself at a future point.
Madrigal Pharmaceuticals Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Madrigal, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to MadrigalMadrigal |
Madrigal Pharmaceuticals Analyst Consensus
Target Price | Advice | # of Analysts | |
373.0 | Strong Buy | 16 | Odds |
Most Madrigal analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Madrigal stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Madrigal Pharmaceuticals, talking to its executives and customers, or listening to Madrigal conference calls.
Madrigal Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Madrigal Pharmaceuticals Technical Analysis
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Madrigal Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Madrigal Pharmaceuticals Trend Analysis
Use this graph to draw trend lines for Madrigal Pharmaceuticals. You can use it to identify possible trend reversals for Madrigal Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Madrigal Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Madrigal Pharmaceuticals Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Madrigal Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of 0.52 , which means Madrigal Pharmaceuticals will continue generating value for investors. It has 122 observation points and a regression sum of squares at 10253.15, which is the sum of squared deviations for the predicted Madrigal Pharmaceuticals price change compared to its average price change.About Madrigal Pharmaceuticals Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Madrigal Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Madrigal Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Madrigal Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Madrigal Pharmaceuticals. By analyzing Madrigal Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Madrigal Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Madrigal Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
2024 | 2025 (projected) | Dividend Yield | 0.008267 | 0.007348 | Price To Sales Ratio | 32.8 | 31.16 |
Madrigal Pharmaceuticals March 28, 2025 Technical Indicators
Most technical analysis of Madrigal help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Madrigal from various momentum indicators to cycle indicators. When you analyze Madrigal charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Risk Adjusted Performance | 0.0672 | |||
Market Risk Adjusted Performance | 0.2409 | |||
Mean Deviation | 2.97 | |||
Semi Deviation | 3.97 | |||
Downside Deviation | 4.15 | |||
Coefficient Of Variation | 1406.48 | |||
Standard Deviation | 4.16 | |||
Variance | 17.34 | |||
Information Ratio | 0.0749 | |||
Jensen Alpha | 0.318 | |||
Total Risk Alpha | 0.415 | |||
Sortino Ratio | 0.0751 | |||
Treynor Ratio | 0.2309 | |||
Maximum Drawdown | 23.14 | |||
Value At Risk | (5.66) | |||
Potential Upside | 7.64 | |||
Downside Variance | 17.24 | |||
Semi Variance | 15.79 | |||
Expected Short fall | (3.01) | |||
Skewness | 0.2987 | |||
Kurtosis | 2.12 |
Madrigal Pharmaceuticals March 28, 2025 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Madrigal stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution | 0.00 | ||
Daily Balance Of Power | (Huge) | ||
Rate Of Daily Change | 0.97 | ||
Day Median Price | 327.02 | ||
Day Typical Price | 327.02 | ||
Price Action Indicator | (5.11) |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Madrigal Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For more information on how to buy Madrigal Stock please use our How to buy in Madrigal Stock guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Madrigal Pharmaceuticals. If investors know Madrigal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Madrigal Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Madrigal Pharmaceuticals is measured differently than its book value, which is the value of Madrigal that is recorded on the company's balance sheet. Investors also form their own opinion of Madrigal Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Madrigal Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Madrigal Pharmaceuticals' market value can be influenced by many factors that don't directly affect Madrigal Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Madrigal Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Madrigal Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Madrigal Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.